| miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β P Bu, L Wang, KY Chen, N Rakhilin, J Sun, A Closa, KL Tung, S King, ... Nature communications 6 (1), 6879, 2015 | 128 | 2015 |
| Enhanced permeability and retention-like extravasation of nanoparticles from the vasculature into tuberculosis granulomas in zebrafish and mouse models F Fenaroli, U Repnik, Y Xu, K Johann, S Van Herck, P Dey, FM Skjeldal, ... ACS nano 12 (8), 8646-8661, 2018 | 103 | 2018 |
| Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis Y Xu, L Wang, MD Zimmerman, KY Chen, L Huang, DJ Fu, F Kaya, ... PLoS pathogens 14 (4), e1006974, 2018 | 67 | 2018 |
| A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer AW Chung, K Anand, AC Anselme, AA Chan, N Gupta, LA Venta, ... Science translational medicine 13 (624), eabj5070, 2021 | 62 | 2021 |
| Potentiating antitumor efficacy through radiation and sustained intratumoral delivery of anti-CD40 and anti-PDL1 HC Liu, DI Viswanath, F Pesaresi, Y Xu, L Zhang, N Di Trani, ... International Journal of Radiation Oncology* Biology* Physics 110 (2), 492-506, 2021 | 53 | 2021 |
| Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting HJ Chen, J Sun, Z Huang, H Hou Jr, M Arcilla, N Rakhilin, DJ Joe, J Choi, ... Nature biotechnology 33 (6), 656-660, 2015 | 35 | 2015 |
| Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer S Singh, N Lee, DA Pedroza, IL Bado, C Hamor, L Zhang, S Aguirre, J Hu, ... Cancer research 82 (12), 2281-2297, 2022 | 32 | 2022 |
| Sustained intratumoral administration of agonist CD40 antibody overcomes immunosuppressive tumor microenvironment in pancreatic cancer HC Liu, D Davila Gonzalez, DI Viswanath, RS Vander Pol, SZ Saunders, ... Advanced Science 10 (9), 2206873, 2023 | 22 | 2023 |
| A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer K Sun, Y Xu, L Zhang, P Niravath, J Darcourt, T Patel, BS Teh, AM Farach, ... Clinical Cancer Research 28 (20), 4392-4401, 2022 | 17 | 2022 |
| Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome BE Jewell, A Xu, D Zhu, MF Huang, L Lu, M Liu, EL Underwood, JH Park, ... PLoS genetics 17 (12), e1009971, 2021 | 14 | 2021 |
| Virus‐mimic mRNA vaccine for cancer treatment C Meng, Z Chen, J Mai, Q Shi, S Tian, L Hinkle, J Li, Z Zhang, M Ramirez, ... Advanced Therapeutics 4 (11), 2100144, 2021 | 14 | 2021 |
| Exploitation of synthetic mRNA to drive immune effector cell recruitment and functional reprogramming in vivo Y Xu, L Huang, JL Kirschman, DA Vanover, PM Tiwari, PJ Santangelo, ... The Journal of Immunology 202 (2), 608-617, 2019 | 9 | 2019 |
| Patients with lung cancer of different racial backgrounds harbor distinct immune cell profiles Y Xu, L Zhang, J Thaiparambil, S Mai, DN Perera, J Zhang, PY Pan, ... Cancer Research Communications 2 (8), 884-893, 2022 | 7 | 2022 |
| A phase II trial of stereotactic radiation therapy and in situ oncolytic virus therapy in metastatic triple-negative breast cancer (mTNBC) patients followed by … K Sun, JE Ensor, Y Xu, L Zhang, C Guerrero, PA Niravath, TA Patel, ... Journal of Clinical Oncology 39 (15_suppl), 1079-1079, 2021 | 7 | 2021 |
| Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer prevention Q Zhang, J Pan, D Xiong, J Zheng, KN McPherson, S Lee, M Huang, Y Xu, ... Frontiers in immunology 14, 1166951, 2023 | 6 | 2023 |
| Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis VK Singh, A Khan, Y Xu, S Mai, L Zhang, A Mishra, BI Restrepo, PY Pan, ... Frontiers in Immunology 13, 865503, 2022 | 6 | 2022 |
| Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer (Adv. Sci. 9/2023) HC Liu, DD Gonzalez, DI Viswanath, RS Vander Pol, SZ Saunders, ... Advanced Science 10 (9), 2023 | 2 | 2023 |
| A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer J Guan, K Sun, CA Guerrero, J Zheng, Y Xu, S Mathur, BS Teh, A Farach, ... International Journal of Radiation Oncology* Biology* Physics 118 (5), 1531-1540, 2024 | 1 | 2024 |
| Molecular architecture of proliferative lupus nephritis as elucidated using 50-plex imaging mass cytometry proteomics ASCLS Titus, Y Tan, P Tran, J Lindblom, M Ivbievbiokun, Y Xu, J Zheng, ... Clinical Immunology 254, 109713, 2023 | 1 | 2023 |
| World Trade Center dust exposure promotes cancer in PTEN-deficient mouse prostates L Wang, Y Xu, L Zhang, K Kang, A Kobryn, K Portman, RE Gordon, ... Cancer research communications 2 (6), 518-532, 2022 | 1 | 2022 |
